R&D Tax Incentives That Fund Growth

R&D tax credits can be a lifeline for early-stage companies and a useful tool for large ones too, but the rules have become increasingly complex, especially when you can’t substantiate what you did. We sit down with Paddy Hobbs of S&W to unpack how the UK R&D tax credit landscape has rightfully evolved from a “how much can I claim” mindset into a compliance-first world where documentation, decision logs, and an audit trail can make or break the benefit. If you’re building a product in software, medtech, engineering, or any science and technology field, this conversation helps you think like HMRC will think. 

We dig into the big structural shift: the UK merged R&D regime (introduced in April 2024) and what it replaces from the old SME and RDEC approaches. Paddy explains what “above-the-line” credit means in real terms, how the cash and tax impact can differ based on profits or losses, and why R&D tax credits look backward while grant funding looks forward. We also talk about the practical risk that scares founders the most: not whether your work is innovative, but whether you can evidence the uncertainty you tackled and the work you actually performed. 

Additionally, we discuss Ireland’s R&D tax credit becoming even more competitive, and its stricter habits around timesheets and record keeping offering a useful model. The US comparison is a different kind of complexity, with federal and state R&D credits that vary widely depending on where you operate and how you structure the work. Finally, we tackle subcontracted R&D and contracts: who initiated the project, who directs it, and who bears technical risk often determines who can claim the relief, especially under the updated UK rules. 

If you want your R&D claim to fund growth without turning into a painful distraction, hit play, take notes, and tighten your process.